It participates in the energy production process, and is responsible for transporting fatty acids to the mitochondria that are inside the body's cells

Weight loss is associated with a decrease in PsO severity and improved quality of life (QoL).41,42 Weight loss greater than 5% is associated with a higher rate of minimum disease activity in patients who are obese or overweight and in treatment for PsO.43,44 The Mediterranean diet, which facilitates weight loss, reduces psoriatic lesions.45 Weight loss in patients with HS leads to a notable decrease in the number of lesions and, in some cases, disease remission.46 Dysfunctional adiposity has been associated with worse indices of CVR and Dermatology Quality of Life Index (DLQI) in patients with HS.47 The decrease in fatty tissue is associated with a decrease in molecular mechanisms that characterize the systemic inflammatory state.48 Diet and exercise are the first therapeutic step but these interventions are, however, often insufficient to achieve favorable outcomes in skin diseases, good response to treatment for these conditions, and a decrease in CVR

Safety Considerations and Contraindications When used under the supervision of qualified professionals, semaglutide is generally considered safe
Individual risk factors such as pre-existing GERD, obesity, and hiatal hernia may increase susceptibility to reflux symptoms
Puig for performing phase 2a statistical analysis
10.1074/jbc.M113.526509 J